DexCom, Inc. (ETR:DC4)
Germany flag Germany · Delayed Price · Currency is EUR
75.66
+1.78 (2.41%)
Last updated: May 9, 2025

DexCom Statistics

Total Valuation

DexCom has a market cap or net worth of EUR 29.68 billion. The enterprise value is 29.57 billion.

Market Cap 29.68B
Enterprise Value 29.57B

Important Dates

The last earnings date was Thursday, May 1, 2025.

Earnings Date May 1, 2025
Ex-Dividend Date n/a

Share Statistics

Current Share Class n/a
Shares Outstanding n/a
Shares Change (YoY) -3.45%
Shares Change (QoQ) +0.20%
Owned by Insiders (%) n/a
Owned by Institutions (%) n/a
Float 389.26M

Valuation Ratios

The trailing PE ratio is 59.94.

PE Ratio 59.94
Forward PE n/a
PS Ratio 7.73
PB Ratio 14.15
P/TBV Ratio 14.93
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 37.32, with an EV/FCF ratio of 55.57.

EV / Earnings 59.72
EV / Sales 8.04
EV / EBITDA 37.32
EV / EBIT 52.71
EV / FCF 55.57

Financial Position

The company has a current ratio of 1.50, with a Debt / Equity ratio of 1.14.

Current Ratio 1.50
Quick Ratio 1.27
Debt / Equity 1.14
Debt / EBITDA 2.89
Debt / FCF 4.49
Interest Coverage 33.12

Financial Efficiency

Return on equity (ROE) is 23.72% and return on invested capital (ROIC) is 8.16%.

Return on Equity (ROE) 23.72%
Return on Assets (ROA) 5.98%
Return on Invested Capital (ROIC) 8.16%
Return on Capital Employed (ROCE) 17.03%
Revenue Per Employee 374,413
Profits Per Employee 48,309
Employee Count 10,300
Asset Turnover 0.63
Inventory Turnover 2.90

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -36.75% in the last 52 weeks.

Beta (5Y) n/a
52-Week Price Change -36.75%
50-Day Moving Average 66.53
200-Day Moving Average 70.06
Relative Strength Index (RSI) 67.88
Average Volume (20 Days) 90

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) 2.29

Income Statement

In the last 12 months, DexCom had revenue of EUR 3.84 billion and earned 495.17 million in profits. Earnings per share was 1.23.

Revenue 3.84B
Gross Profit 2.28B
Operating Income 585.28M
Pretax Income 676.14M
Net Income 495.17M
EBITDA 793.64M
EBIT 585.28M
Earnings Per Share (EPS) 1.23
Full Income Statement

Balance Sheet

The company has 2.50 billion in cash and 2.39 billion in debt, giving a net cash position of 109.36 million.

Cash & Cash Equivalents 2.50B
Total Debt 2.39B
Net Cash 109.36M
Net Cash Per Share n/a
Equity (Book Value) 2.10B
Book Value Per Share 5.35
Working Capital 1.40B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 891.99 million and capital expenditures -359.81 million, giving a free cash flow of 532.18 million.

Operating Cash Flow 891.99M
Capital Expenditures -359.81M
Free Cash Flow 532.18M
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 59.43%, with operating and profit margins of 15.25% and 12.90%.

Gross Margin 59.43%
Operating Margin 15.25%
Pretax Margin 17.62%
Profit Margin 12.90%
EBITDA Margin 20.68%
EBIT Margin 15.25%
FCF Margin 13.87%

Dividends & Yields

DexCom does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield 3.45%
Shareholder Yield 3.45%
Earnings Yield 1.67%
FCF Yield 1.79%

Stock Splits

The last stock split was on June 13, 2022. It was a forward split with a ratio of 4.

Last Split Date Jun 13, 2022
Split Type Forward
Split Ratio 4

Scores

DexCom has an Altman Z-Score of 6.35.

Altman Z-Score 6.35
Piotroski F-Score n/a